Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Rehabilitación (Madr., Ed. impr.) ; 57(1): 100732-100732, Ene-Mar. 2023. tab, graf
Article in Spanish | IBECS | ID: ibc-214200

ABSTRACT

Introducción: La actividad física es esencial en la población con artrosis, sin embargo, el confinamiento durante la pandemia por COVID obligó al cambio en los estilos de vida. Se llevó a cabo un estudio observacional y descriptivo con el objetivo de evaluar el ejercicio físico realizado en personas con patología osteoarticular degenerativa (POD) durante la pandemia por COVID-19. Material y métodos: Se realizó una encuesta telefónica a personas mayores de 60 años con POD atendidos previamente en el Hospital Central de la Cruz Roja, valorando el ejercicio físico durante el confinamiento por pandemia COVID-19. Se analizaron las variables (tiempo de ejercicio físico, causas si el ejercicio fue reducido, y la intensidad de dolor) y se compararon con la situación previa al confinamiento domiciliario. Resultados: Se incluyeron un total de 33 pacientes (ocho hombres, 25 mujeres), con una edad media de 75,6 años. La poliartrosis fue el diagnóstico más frecuente. El 51,5% realizaban la misma cantidad de ejercicio físico, el 21,21% realizaban más y 24,2% menos que antes. Solo el 6,1% realizaba más de una hora al día de actividad. El 36,4% tenían más dolor que previamente. Conclusiones: Aunque existe una alta adherencia a los ejercicios aprendidos en el servicio de rehabilitación, el confinamiento por COVID-19 ha tenido un efecto negativo en el nivel de ejercicio realizado por los pacientes con POD. Es recomendable incentivar el ejercicio físico durante períodos de confinamiento.(AU)


Introduction: Physical activity is essential in the osteoarthritis population, however, confinement during the COVID pandemic forced lifestyle changes. An observational and descriptive study was conducted to assess physical exercise in people with degenerative osteoarticular disease (DOD) during the COVID-19 pandemic. Material and methods: A telephone survey was conducted among people over 60 years of age with DOD previously treated at the Hospital Central de la Cruz Roja, assessing physical exercise during the COVID-19 pandemic confinement. The variables (time of physical exercise, causes if exercise was reduced, and pain intensity) were analysed and compared with the situation prior to home confinement. Results: A total of 33 patients (8 men, 25 women) were included, with a mean age of 75.6 years. Polyarthrosis was the most frequent diagnosis. 51.5% performed the same amount of physical exercise, 21.21% performed more and 24.2% less than before. Only 6.1% performed more than 1 h a day of activity. 36.4% had more pain than previously. Conclusions: Although there is a high adherence to the exercises learned in the rehabilitation service, COVID-19 confinement has had a negative effect on the level of exercise performed by POD patients. It is advisable to encourage physical exercise during periods of lockdown.(AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Controlled Confinement , Exercise , Joint Diseases , Pandemics , Coronavirus Infections , Severe acute respiratory syndrome-related coronavirus , Pain Measurement , Rehabilitation , Spain , Surveys and Questionnaires , Epidemiology, Descriptive , Cross-Sectional Studies
2.
Rehabilitacion (Madr) ; 57(1): 100732, 2023.
Article in Spanish | MEDLINE | ID: mdl-35545482

ABSTRACT

INTRODUCTION: Physical activity is essential in the osteoarthritis population, however, confinement during the COVID pandemic forced lifestyle changes. An observational and descriptive study was conducted to assess physical exercise in people with degenerative osteoarticular disease (DOD) during the COVID-19 pandemic. MATERIAL AND METHODS: A telephone survey was conducted among people over 60 years of age with DOD previously treated at the Hospital Central de la Cruz Roja, assessing physical exercise during the COVID-19 pandemic confinement. The variables (time of physical exercise, causes if exercise was reduced, and pain intensity) were analysed and compared with the situation prior to home confinement. RESULTS: A total of 33 patients (8 men, 25 women) were included, with a mean age of 75.6 years. Polyarthrosis was the most frequent diagnosis. 51.5% performed the same amount of physical exercise, 21.21% performed more and 24.2% less than before. Only 6.1% performed more than 1 h a day of activity. 36.4% had more pain than previously. CONCLUSIONS: Although there is a high adherence to the exercises learned in the rehabilitation service, COVID-19 confinement has had a negative effect on the level of exercise performed by POD patients. It is advisable to encourage physical exercise during periods of lockdown.


Subject(s)
COVID-19 , Osteoarthritis , Aged , Female , Humans , Male , Middle Aged , Communicable Disease Control , Exercise , Pandemics , SARS-CoV-2
3.
Pediatr Transplant ; 6(2): 127-31, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12000468

ABSTRACT

To evaluate the effect of recombinant human growth hormone (rhGH) treatment on the lipid profile of pediatric renal transplant patients, we studied nine children treated with rhGH for 1 yr and a control group of 12 untreated patients matched in terms of age, renal transplant function and post-transplant follow-up. The levels of lipoprotein (a [Lp(a)], cholesterol, triglycerides, apolipoprotein A (APO A) and apolipoprotein B (APO B), and the APO B/APO A ratio, were determined at baseline and after 6 and 12 months of follow-up. RhGH therapy had no effect on cholesterol, triglycerides or apolipoproteins. Mean serum Lp(a) levels increased from 6.7 +/- 5.7 mg/dL at baseline to 11.8 +/- 10.7 after 6 months (p = 0.018) and 13.6 +/- 15.1 after 12 months of rhGH treatment (p = 0.04), but did not change in the control group. Lp(a) is a risk factor for cardiovascular morbidity, and increased Lp(a) levels may be a side-effect of rhGH treatment in renal transplant patients. Although long-term follow-up of a large number of patients is needed to establish the duration and extent of the effects of rhGH treatment on Lp(a) levels in transplanted children, serum Lp(a) levels should be carefully monitored in those receiving rhGH therapy.


Subject(s)
Graft Rejection/etiology , Growth Disorders/drug therapy , Growth Hormone/administration & dosage , Growth Hormone/adverse effects , Kidney Transplantation/methods , Lipoprotein(a)/drug effects , Adolescent , Analysis of Variance , Child , Female , Graft Rejection/prevention & control , Growth Disorders/diagnosis , Humans , Lipoprotein(a)/analysis , Male , Monitoring, Physiologic , Probability , Prognosis , Regression Analysis , Risk Assessment , Risk Factors
4.
Perit Dial Int ; 21(2): 172-9, 2001.
Article in English | MEDLINE | ID: mdl-11330562

ABSTRACT

OBJECTIVE: To evaluate the sensitivity of anthropometry and bioelectrical impedance analysis (BIA) in detecting alterations in body composition of children treated with peritoneal dialysis (PD), and to determine the prevalence of malnutrition in this population, in short- and long-term PD duration, using anthropometric and BIA-derived indices. PATIENTS: Eighteen children treated with automated PD (11 males, 7 females; mean age 8.7 +/- 4.7 years). DESIGN: Eighteen patients were studied using anthropometry and BIA at the start (t0) and after 6 months (t1) of PD, 15 of these patients at 12 months (t2), and 8 at 24 months (t3) of PD. Midarm muscle circumference (MAMC), arm muscle area (AMA), and arm fat area (AFA) were calculated from anthropometric measures according to Frisancho (FrisanchoAR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981; 34:2540-5.). The bioelectrical measures of resistance (R) and reactance (Xc) were obtained directly from the impedance signal; phase angle (PA) and distance (D) were calculated using mathematical formulas. Nutritional status was assessed by anthropometric measurements and BIA-derived indices, expressed as standard deviation scores (SDS), and by a score system based on BIA and anthropometric parameters. The percentage of children with values of anthropometric and BIA-derived indices below the 3rd percentile or between the 3rd and 25th percentiles, and the percentage of children with scores of 7-12 and 4-6 were calculated in order to detect patients with severe or moderate derangement of nutritional status. RESULTS: The mean SDS values of Xc, PA, and D significantly improved (p = 0.05, p = 0.001, p = 0.02) during the first 6 months of PD and remained almost stable during the following months. The SDS values of the anthropometric indices were less compromised than those of the BIA-derived indices, particularly at the start of dialysis. By 6 months, the percentages of children with values of BIA and anthropometric indices below the 3rd percentile had decreased. The percentages of patients with moderate and severe derangement of BIA and anthropometric indices remained substantially unchanged after 12 months. However, at 24 months, the percentage of patients with moderate derangement of BIA indices increased. All these findings were confirmed by the nutritional score system. CONCLUSION: BIA is more sensitive than anthropometry in detecting alterations in body composition of children on PD. The prevalence of malnutrition, high at the commencement of PD, decreases during the first year of treatment but not over the long term.


Subject(s)
Anthropometry , Body Composition , Nutrition Disorders/diagnosis , Peritoneal Dialysis/adverse effects , Adolescent , Child , Child, Preschool , Electric Impedance , Female , Humans , Infant , Male , Nutrition Disorders/etiology , Nutritional Status , Sensitivity and Specificity
5.
Pediatr Nephrol ; 16(1): 1-7, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11198593

ABSTRACT

To evaluate the efficacy of renal transplantation in small pediatric patients, we have reviewed 41 allografts performed in 39 children (28 M/11 F) less than 6 years of age between 1987 and 1998 in the North Italy Transplant Program. Of these patients, 39 had a cadaver donor and 2 a living-related donor, with ages ranging from 20 days to 35 years. The mean follow-up was 56 months. Graft survival was 74.5% and 70.5% at 1 and 5 years, respectively. The causes of graft lost were acute rejection (4), graft vascular thrombosis (4), and hemolytic uremic syndrome recurrence (1). Only 1 patient has died due to chickenpox. Double and triple immunosuppressive therapies were used in 63% and 37% of patients, respectively, on the basis of different center protocols, without differences in graft survival. Steroids were successfully administered on alternate days in 37% of patients, 6-12 months after transplantation. Thrombosis was reported in 2 of 6 kidneys from donors less than 1 year of age and in 2 of 35 donors older than 1 year (P < 0.05). Thirty rejections occurred in 23 patients: 7 episodes were steroid resistant and were treated with ATG/OKT3. Thirty-four infections were reported in 16 of 41 patients; of these 17 were viral, 14 bacterial, and 3 due to Mycoplasma. Four surgical complications were reported: 1 graft artery stenosis, 1 ureteral stenosis, 1 urinary leak, and 1 lymphocele. Mean height standard deviation score improved from -2.0 +/- 1.3 pre transplantation to -1.8 +/- 1.4, -1.5 +/- 1.3, and -1.5 +/- 1.5 at 1, 2, and 5 years post transplantation. Linear growth was significantly better in infants treated with alternate-day steroids. Hypertension was a frequent complication, since 19 of the 30 patients with a 5-year follow-up were still being treated with antihypertensive drugs. In conclusion, graft survival in patients less than 6 years old is satisfactory and similar to that obtained in children aged from 6 to 18 years (70.5% vs. 78.9% at 5 years, P = NS). Consequently, since there are many difficulties in managing infants on maintenance dialysis, an early transplant should be considered. Donors older than 24 months carry a low risk of vascular thrombosis and may be successfully grafted in infants.


Subject(s)
Kidney Transplantation , Child Development , Child, Preschool , Female , Follow-Up Studies , Glomerular Filtration Rate , Graft Rejection/epidemiology , Heart Transplantation , Humans , Immunosuppression Therapy , Incidence , Infant, Newborn , Infections/etiology , Kidney Diseases/surgery , Kidney Transplantation/adverse effects , Liver Transplantation , Male , Postoperative Complications , Recurrence , Survival Analysis , Thrombosis/etiology , Treatment Outcome
6.
Pediatr Nephrol ; 15(1-2): 25-30, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11095006

ABSTRACT

To develop models to estimate nitrogen (N) losses of children on chronic peritoneal dialysis (CPD) from easily measurable indexes and laboratory tests, we measured the N content and all nitrogenous compounds in dialysate (D), urine (U), and feces over 3 days in 19 pediatric patients on CPD. Total measured N losses (TNm) were 5.56+/-2.26 g/day (69.9+/-11.1% in dialysate, 16.3+/-10.6% in urine, and 13.6+/-4.6% in feces). Correlation coefficients between measured dialysate and urinary N losses and the single nitrogenous compounds indicated values of over 0.9 only for urea in dialysate and urine; fecal N losses correlated well with body surface area (BSA). Taking into account these correlations, we developed a univariate additive model and three multivariate models to predict total estimated N losses (TNe). The best prediction of TNm was obtained with model 3, which considered not only urea output in dialysate and urine but also dialysate protein loss and BSA: TNe (g/day)=0.03+/-1.138 UN urea+0.99 DN urea+1.18 BSA+0.965 DN protein. A confirmatory analysis performed on a second group of 23 pediatric patients on CPD, using all four models, showed a higher percentage of studies with a relative difference between TNm and TNe less than 10% for model 3 than for the other models. Thus, N losses of pediatric patients on CPD can be estimated from measured urea and protein losses in dialysate and urea loss in urine, together with BSA.


Subject(s)
Models, Biological , Nitrogen/metabolism , Peritoneal Dialysis/adverse effects , Adolescent , Analysis of Variance , Body Surface Area , Child , Child, Preschool , Creatinine/metabolism , Feces/chemistry , Humans , Nitrogen/urine , Peritoneal Dialysis, Continuous Ambulatory , Reproducibility of Results
7.
Pediatr Nephrol ; 13(3): 253-8, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10353417

ABSTRACT

Protein and energy requirements of children on automated peritoneal dialysis (APD) have still not been sufficiently well defined, although their adequacy is important to maintain a positive nitrogen (N) balance and prevent malnutrition. We carried out 42 studies to estimate N balance in 31 children over 3 years on APD for 19.8+/-15.7 months. Twenty metabolic studies were performed in patients dialysed for less than 1 year (7.2+/-3.3 months) and 22 in patients treated for more than 1 year (31.3+/-13.6 months). The mean estimated N balance of all metabolic studies was 57.5+/-62.8 mg/kg per day. In only 21 of 42 studies was N balance estimated to be over 50 mg/kg per day, which is considered adequate to meet N requirements for all metabolic needs and growth of uremic children. Estimated N balance correlated significantly with dietary protein intake (r=0.671, P=0.0001) and total energy intake (r=0.489, P=0.001). Using the equations of correlation, the values of dietary protein intake [=144% recommended dietary allowance (RDA)] and total energy intake (89% RDA) required to obtain an estimated N balance >50 mg/kg per day were calculated. Significantly lower estimated N balance values were obtained in the studies performed on patients on APD for over 1 year (36.09+/-54.02 mg/kg per day) than in patients treated for less than 1 year (81.11+/-64.70 mg/kg per day). In conclusion, based on the values of estimated N balance, we were able to establish adequate dietary protein and energy requirements for children on APD.


Subject(s)
Dietary Proteins/administration & dosage , Dietary Proteins/metabolism , Energy Intake/physiology , Nitrogen/metabolism , Peritoneal Dialysis , Adolescent , Adult , Age Factors , Child , Child, Preschool , Dialysis Solutions/metabolism , Feces/chemistry , Humans , Kidney Diseases/metabolism , Kidney Diseases/therapy , Nitrogen Compounds/analysis , Nitrogen Compounds/urine , Nutritional Status
8.
Transpl Int ; 11 Suppl 1: S69-72, 1998.
Article in English | MEDLINE | ID: mdl-9664947

ABSTRACT

Renal-transplanted children may present stunted growth, negative nitrogen balance (Nb), and alterations in body composition. Recombinant human growth hormone (rhGH) is a potent anabolic agent which improves nutritional status and Nb. In renal-transplanted children, rhGH increases growth velocity but its effect on nutritional status has not been reported. We evaluated the effect of 6 months of rhGH treatment on Nb, urea nitrogen appearance (UNA), anthropometric indexes, and growth velocity in 14 pediatric patients with a renal transplant. Nb improved significantly (P = 0.02) and was accompanied by a decrease of UNA. A significant improvement was observed also in mid-arm muscle circumference (P = 0.002), arm muscle are (P = 0.001), and arm fat are (P = 0.017). Growth velocity increased in prepubertal patients (P = 0.003). Creatinine clearance and the number of rejection episodes were not affected by rhGH treatment. In conclusion, short-term administration of rhGH improves Nb and UNA as well as the main indexes of body composition.


Subject(s)
Growth/drug effects , Human Growth Hormone/pharmacology , Kidney Transplantation , Adolescent , Body Composition , Child , Female , Humans , Male , Nitrogen/metabolism , Time Factors , Urea/metabolism
9.
Adv Perit Dial ; 13: 267-70, 1997.
Article in English | MEDLINE | ID: mdl-9360696

ABSTRACT

Dietary protein restriction, progressive loss of renal adaptive capacity, and uremic toxicity may contribute to the development of malnutrition and water retention in severe chronic renal failure (CRF). Malnutrition is also common in children treated with chronic peritoneal dialysis (CPD). It is not clear how the start of CPD influences body composition of children with CRF. We used a bioimpedance analysis device (BIA 101S Akern) to measure resistance and reactance in 7 children, with residual creatinine clearance of about 5 mL/min/1.73 m2 at the start of CPD (t0) and repeated the test 6 months later (t1). Distance (D), which is considered a reliable index of hydration and nutrition, was obtained from resistance (R) and reactance (Xc) by calculating phase angle (PA). BIA values of our patients were compared with those of healthy children of the same statural age from a series of 551 controls. There was an overall improvement of Xc, PA, and D after 6 months of CPD. In some cases D did not normalize, which indicates that some children with CRF on a restricted protein diet may present changes of body composition that are only partially reversed by short-term CPD. The present indications for the start of CPD should probably be reassessed, at least in some cases, to prevent malnutrition.


Subject(s)
Body Composition , Electric Impedance , Peritoneal Dialysis , Child , Dietary Proteins/administration & dosage , Female , Humans , Kidney Failure, Chronic/therapy , Male , Nutritional Status , Time Factors
10.
Perit Dial Int ; 16(3): 295-301, 1996.
Article in English | MEDLINE | ID: mdl-8761544

ABSTRACT

OBJECTIVE: To propose a simplified equilibration test specific for tidal peritoneal dialysis (TPD) that will overcome the inconveniences of the measurement of TPD peritoneal solute clearances through whole dialysate collection. This will enable the prediction of peritoneal creatinine and urea clearances, the suitability of patients for TPD, and routine assessment of TPD delivery. DESIGN: In a prospective study, patients had a standardized TPD run, and dialysate-to-plasma (D/P) ratios for creatinine and urea were calculated at various TPD and peritoneal equilibration test (PET) time points and on total TPD dialysate. Solute clearances were estimated and measured, and correlation coefficients were obtained among all these variables. SETTING: Dialysis unit of a pediatric nephrology department and patients' homes. PATIENTS: Eleven pediatric patients with end-stage renal disease in stable clinical conditions treated with TPD. INTERVENTIONS: Dialysate and blood sample collections. MAIN OUTCOME MEASURES: D/P ratios for creatinine and urea at the fifth and seventh TPD exchanges, at 15-, 30-, 60-, and 120-minute PET times, and on total TPD dialysate and TPD peritoneal creatinine and urea clearances. RESULTS: Correlation coefficients between PET-derived and total TPD dialysate-derived D/P ratios, and those between PET-derived and measured creatinine and urea clearances were more significant at the 120-minute PET time point compared with the other PET time points. Best correlations were obtained at the fifth and seventh TPD exchanges. D/P ratios for creatinine and urea of the fifth and seventh TPD exchanges correlated significantly with the D/P ratios calculated from total TPD dialysate. A significant correlation was also found between peritoneal creatinine and urea clearances on total dialysate volume (measured clearances) and those derived from the dialysate collection of the fifth and seventh TPD exchanges (estimated clearances)--that based on the seventh exchange being slightly more significant. Moreover, the estimated clearances derived from the seventh exchange were within 10% of the measured value in 90.9% of patients both for creatinine and urea. CONCLUSION: The significant correlation between measured and estimated peritoneal creatinine and urea clearances and the low percentage of underestimates of measured clearances obtained using the seventh TPD exchange-derived indices confirm the accuracy of the D/P ratios for creatinine and urea derived from any exchange after the fifth (preferably the seventh) of a standardized TPD run in estimating peritoneal creatinine and urea clearances. This method could represent a simple and accurate means for prescribing TPD and routinely assessing TPD delivery.


Subject(s)
Peritoneal Dialysis/methods , Peritoneum/metabolism , Child , Creatinine/metabolism , Humans , Prospective Studies , Urea/metabolism
11.
Pediatr Nephrol ; 10(1): 73-5, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8611363

ABSTRACT

This case report describes infantile nephrotic syndrome (NS) in a baby girl with a clinically severe cytomegalovirus (CMV) infection. Culture of the baby's urine was positive for CMV and IgM anti-CMV antibodies were detected. After an unsuccessful course of corticosteroids, gancyclovir treatment was started and a remission of cutaneous, pulmonary, and renal symptoms was achieved. As the mother also developed NS at the end of pregnancy, a common etiology could be postulated, although there were no signs of recent CMV infection in the mother, only anti-CMV IgG. The relationship between CMV infection and glomerular disease is still unclear; NS may represent another manifestation of CMV disease.


Subject(s)
Cytomegalovirus Infections/virology , Nephrotic Syndrome/virology , Adrenal Cortex Hormones/therapeutic use , Adult , Antibodies, Viral/analysis , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/pathology , Female , Humans , Immunoglobulin G/urine , Immunoglobulin M/urine , Infant, Newborn , Kidney/pathology , Nephrotic Syndrome/drug therapy , Nephrotic Syndrome/pathology , Pregnancy
12.
Pediatr Nephrol ; 9(3): 329-32, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7632525

ABSTRACT

To achieve more adequate dialysis in a shorter treatment time, seven children, characterized as high/high average (H/HA, 5 patients) and low/low average (L/LA, 2 patients) transporters according to the peritoneal equilibration test, were treated with tidal peritoneal dialysis (TPD) for 13.7 +/- 5.7 months, after being treated with nightly intermittent peritoneal dialysis (NIPD) for a similar period. We determined the TPD prescription necessary to provide improved clearances compared with NIPD within the same or less treatment time. Dialysis flow rate was significantly higher in TPD than NIPD, due to a reduction of dwell time and an increase in the number of exchanges. Peritoneal and total clearances of urea and creatinine were higher, whereas serum creatinine and urea nitrogen levels were lower and treatment duration shorter during TPD than NIPD, notwithstanding a decrease of residual renal function. Moreover, a mean time-averaged blood urea nitrogen level as low as 48.5 +/- 11.6 mg/dl was achieved during TPD. The improvement was more significant in H/HA than in L/LA patients.


Subject(s)
Kidney Failure, Chronic/therapy , Peritoneal Dialysis/methods , Adolescent , Blood Urea Nitrogen , Child , Creatinine/blood , Dietary Proteins/administration & dosage , Female , Humans , Kidney Failure, Chronic/metabolism , Male , Urea/blood
13.
Pediatr Med Chir ; 17(1): 9-15, 1995.
Article in Italian | MEDLINE | ID: mdl-7739938

ABSTRACT

The nephrotic syndrome persists unchanged after the initial course of steroid therapy in 15 to 20% of patients. In such cases, the severity of the condition lies essentially in the risk of developing end-stage renal failure. This occurs in one third to one half of the cases. Furthermore, some of these children are at risk for recurrence of their original disease in the transplanted kidney. The course of steroid resistant nephrotic syndrome (SRNS) is usually punctuated by the need for numerous hospitalizations for mobilization of edema and treatment of infection. The treatment of patients with SRNS presents a major problem in the field of pediatric nephrology. Immunosuppressive agents may be efficient in some of steroid-resistant patients, inducing remission of proteinuria and protecting renal function. Unfortunately, all these agents have a low therapeutic index. Thus, in deciding whether, how, and when to use immunomodulating drugs, the nephrologist should be aware of their potential side effects, of the results that may be obtained and of the possible strategies for maximizing their therapeutic index.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Alkylating Agents/therapeutic use , Immunosuppressive Agents/therapeutic use , Nephrotic Syndrome/drug therapy , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/adverse effects , Alkylating Agents/administration & dosage , Alkylating Agents/adverse effects , Child , Chlorambucil/administration & dosage , Chlorambucil/adverse effects , Chlorambucil/therapeutic use , Controlled Clinical Trials as Topic , Cyclophosphamide/administration & dosage , Cyclophosphamide/adverse effects , Cyclophosphamide/therapeutic use , Cyclosporine/administration & dosage , Cyclosporine/adverse effects , Cyclosporine/therapeutic use , Drug Resistance, Multiple , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/adverse effects , Kidney Transplantation , Nephrotic Syndrome/complications , Prednisone/administration & dosage , Prednisone/adverse effects , Prednisone/therapeutic use , Recurrence , Time Factors
14.
Adv Perit Dial ; 10: 112-5, 1994.
Article in English | MEDLINE | ID: mdl-7999806

ABSTRACT

Prediction of suitability of patients for tidal peritoneal dialysis (TPD) treatment based on the peritoneal equilibration test (PET) may be hypothetically subject to errors, due to the difference between the long equilibration times of the PET and the short dwell times currently utilized during TPD. Eleven patients, mean age 12.4 +/- 3.3 years, mean body weight 34.2 +/- 15kg, had both a standardized TPD run (initial fill volume 40 mL/kg, tidal volume 50%, dwell time 10 min, treatment time 8 h) and a PET performed. D/P ratios for creatinine and urea were calculated at the 5th and 7th TPD exchanges (approximating equilibration time of the TPD run), at the time points of the PET and on the total TPD dialysate volume. D/P ratios for creatinine and urea of the 5th and, even more, the 7th TPD exchange, and D/P ratios obtained from total TPD dialysate were significantly correlated overall (r = 0.96, p < 0.0001 for 5th D/P creatinine and urea; r = 0.98, p < 0.0001 for 7th D/P creatinine and urea). Correlation coefficients between PET-derived and total TPD dialysate-derived D/P ratios were generally poor or only modest. Thus, it is possible to predict TPD clearance, and consequently the suitability of patients for TPD, knowing the D/P ratios for creatinine and urea at the 7th TPD exchange of a standardized TPD run. Our data could represent a new reliable test for TPD prescription.


Subject(s)
Peritoneal Dialysis , Adolescent , Child , Creatinine/metabolism , Humans , Peritoneal Dialysis/methods , Urea/metabolism
15.
Ren Fail ; 16(5): 629-36, 1994.
Article in English | MEDLINE | ID: mdl-7855318

ABSTRACT

Clinical variables and laboratory and histologic findings were evaluated in 53 children with IgA nephropathy, of whom 44 were followed for a mean period of 6.2 years (range 1.2-14). At the end of the follow-up 8 patients (18.2%) had had no urinary anomalies for at least 1 year (stage A disease), 28 (63.6%) had microscopic hematuria with proteinuria < 1 g/m2/day (stage B), 5 (11.4%) had proteinuria > 1 g/m2/day (stage C), and 3 (6.8%) had chronic renal insufficiency (stage D). None of the patients in apparent remission presented with elevated serum IgA levels at disease onset. Gross or microscopic hematuria at onset correlated with stage A/B disease at the end of follow-up (p < .05) whereas the presence of proteinuria or nephritic syndrome at onset correlated with stage C/D disease after follow-up (p > .05). Presenting features of gross or microscopic hematuria without or with proteinuria (< 0.5 g/m2/day) correlated (p < .001) with minimal glomerular abnormalities at biopsy, whereas patients with nephritic syndrome had more severe histologic pictures. The presence of proliferative glomerulonephritis with crescents correlated (p < .0001) with poor outcome. The results demonstrate that the prognosis of IgA nephropathy in childhood must be viewed with caution and that outcome correlates with mode of onset and severity of the renal pathology.


Subject(s)
Glomerulonephritis, IGA/diagnosis , Analysis of Variance , Biopsy, Needle , Chi-Square Distribution , Child , Child, Preschool , Female , Follow-Up Studies , Glomerulonephritis, IGA/classification , Glomerulonephritis, IGA/pathology , Glomerulonephritis, IGA/therapy , Humans , Italy , Kidney/pathology , Male , Prognosis , Remission Induction , Treatment Outcome
16.
Perit Dial Int ; 13 Suppl 2: S260-2, 1993.
Article in English | MEDLINE | ID: mdl-8399583

ABSTRACT

The peritoneal equilibration test (PET) is routinely performed in adults treated with chronic peritoneal dialysis to assess the peritoneal transport rate and to optimize treatment prescription. Only a few and not well-standardized studies on the PET have been reported in children. Twenty-six PET's were performed in 16 children, mean age 10.9 +/- 4.9 years, mean body weight (BW) 26.8 +/- 11.9 kg, treated with nightly intermittent peritoneal dialysis (NIPD). The PET was performed according to Twardowski. Forty mL/kg BW of 2.27% glucose solution were infused at a rate of 10 mL/kg BW every 2 minutes. In the simplified test, dialysate samples were taken at dwell times 0, 2 and 4 hours for glucose and creatinine. A blood sample was taken after a 2-hour dwell time for the same parameters. The standard PET (8 patients) consisted of dialysate samples at 0, 15, 30, 60, 120, and 240 minutes and blood samples at 0 and 240 minutes. Mean D/P ratio for corrected creatinine and D/D0 ratio for glucose at 2 hours were 51.6 +/- 11.6 and 50.4 +/- 9, respectively; at 4 hours 69.6 +/- 12 and 34.4 +/- 9.8, respectively. There was good correlation between D/P creatinine and D/D0 glucose at 4 hours (p < 0.0001). Patients were classified as high (3 cases), high-average (5), low-average (6), and low (2) transporters. A statistically significant difference was found between the curves obtained by the simplified PET and those of the standard PET in the first hour (r = 0.66; p < 0.05). In conclusion, the PET, modified for use in children, gave reliable and reproducible results.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Peritoneal Dialysis , Peritoneum/metabolism , Biological Transport , Child , Child, Preschool , Creatinine/metabolism , Evaluation Studies as Topic , Glucose/metabolism , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...